Review



cd36 nm 007643 mouse tagged orf clone lentiviral particle  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    OriGene cd36 nm 007643 mouse tagged orf clone lentiviral particle
    Changes in expression of vascular EC receptors during a T. brucei infection (A) Expression of seven EC receptors (P-selectin, E-selectin, ICAM1, ICAM2, VCAM1, PECAM1, and <t>CD36)</t> measured by intravital imaging after injection of antibodies coupled to A647 fluorophore. Representative intravital images relative to g-WAT and pancreas. Scale bars: 50 μm. (B) Heatmap shows MFI values for each receptor measured in each organ on uninfected and d6-infected mice. Measurements are the mean value of at least 100 vessels measured per condition. All relevant data used to generate this figure are included in (tabs 15 and 16). See also and and .
    Cd36 Nm 007643 Mouse Tagged Orf Clone Lentiviral Particle, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/Cd36+(NM_007643)+Mouse+Tagged+ORF+Clone/pmc08480282-46-0-9
    Average 90 stars, based on 1 article reviews
    cd36 nm 007643 mouse tagged orf clone lentiviral particle - by Bioz Stars, 2026-11
    90/100 stars

    Images

    1) Product Images from "Organotypic endothelial adhesion molecules are key for Trypanosoma brucei tropism and virulence"

    Article Title: Organotypic endothelial adhesion molecules are key for Trypanosoma brucei tropism and virulence

    Journal: Cell Reports

    doi: 10.1016/j.celrep.2021.109741

    Changes in expression of vascular EC receptors during a T. brucei infection (A) Expression of seven EC receptors (P-selectin, E-selectin, ICAM1, ICAM2, VCAM1, PECAM1, and CD36) measured by intravital imaging after injection of antibodies coupled to A647 fluorophore. Representative intravital images relative to g-WAT and pancreas. Scale bars: 50 μm. (B) Heatmap shows MFI values for each receptor measured in each organ on uninfected and d6-infected mice. Measurements are the mean value of at least 100 vessels measured per condition. All relevant data used to generate this figure are included in (tabs 15 and 16). See also and and .
    Figure Legend Snippet: Changes in expression of vascular EC receptors during a T. brucei infection (A) Expression of seven EC receptors (P-selectin, E-selectin, ICAM1, ICAM2, VCAM1, PECAM1, and CD36) measured by intravital imaging after injection of antibodies coupled to A647 fluorophore. Representative intravital images relative to g-WAT and pancreas. Scale bars: 50 μm. (B) Heatmap shows MFI values for each receptor measured in each organ on uninfected and d6-infected mice. Measurements are the mean value of at least 100 vessels measured per condition. All relevant data used to generate this figure are included in (tabs 15 and 16). See also and and .

    Techniques Used: Expressing, Infection, Imaging, Injection

    Blocking specific vascular EC receptors reduced T. brucei virulence and extravasation (A) Parasitemia was followed by bioluminescence in mice treated with blocking antibodies 2 days prior to and during the initial 6 days of infection. (B) Boxplots of mean parasitemia during the first parasite peak (d5–8). (C) Survival of antibody-treated mice. ECl receptors recognized by antibodies are indicated in the key. (D) Heatmap of parasite enrichment in multiple organs on d6 post-infection, calculated from the percentage of detected parasites per area in the extravascular space, in treated versus untreated conditions. Zero was set as the baseline control, and data are plotted in a log10 scale. Each column represents a different antibody treatment of infected mice. Graphs in the middle and right panels show the respective quantitative values of parasite density in g-WAT and pancreas. All other organs are included in <xref ref-type=Figure S10 . Error bars show SD. (E) Parasitemia was followed by hemocytometer in mice homozygous (CD36 −/− ), heterozygous (CD36 +/− ), or wild-type (CD36 +/+ ) for CD36 and mice treated with blocking antibodies 2 days prior to and during the initial 6 days of infection. (F) Boxplots of the mean parasitemia during the first peak (d5–8). (G) Mouse survival as assessed in genetically modified mice. (H) Heatmap of parasite enrichment in multiple organs on day 6 post-infection, calculated from the ratio of detected parasites per area in the extravascular space, in mice homozygous or heterozygous for CD36 depletion versus wild-type littermates. Zero was set as the baseline control, and data are plotted in a log10 scale. Graphs in the middle and right panels show the extravascular parasite density in g-WAT and pancreas on day 6 post-infection. For all experiments, measurements correspond to triplicate experiments obtained from 9–12 mice. Heatmaps correspond to the score of at least 100 measurements from at least 12 individual mice. Significance relative to untreated controls is shown as ∗∗∗ p < 0.001, ∗∗ p < 0.01, or ∗ p < 0.05. Error bars show SD. All relevant data used to generate this figure are included in (tabs 17–20). See also and . " title="... Parasitemia was followed by hemocytometer in mice homozygous (CD36 −/− ), heterozygous (CD36 +/− ), or wild-type ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Blocking specific vascular EC receptors reduced T. brucei virulence and extravasation (A) Parasitemia was followed by bioluminescence in mice treated with blocking antibodies 2 days prior to and during the initial 6 days of infection. (B) Boxplots of mean parasitemia during the first parasite peak (d5–8). (C) Survival of antibody-treated mice. ECl receptors recognized by antibodies are indicated in the key. (D) Heatmap of parasite enrichment in multiple organs on d6 post-infection, calculated from the percentage of detected parasites per area in the extravascular space, in treated versus untreated conditions. Zero was set as the baseline control, and data are plotted in a log10 scale. Each column represents a different antibody treatment of infected mice. Graphs in the middle and right panels show the respective quantitative values of parasite density in g-WAT and pancreas. All other organs are included in Figure S10 . Error bars show SD. (E) Parasitemia was followed by hemocytometer in mice homozygous (CD36 −/− ), heterozygous (CD36 +/− ), or wild-type (CD36 +/+ ) for CD36 and mice treated with blocking antibodies 2 days prior to and during the initial 6 days of infection. (F) Boxplots of the mean parasitemia during the first peak (d5–8). (G) Mouse survival as assessed in genetically modified mice. (H) Heatmap of parasite enrichment in multiple organs on day 6 post-infection, calculated from the ratio of detected parasites per area in the extravascular space, in mice homozygous or heterozygous for CD36 depletion versus wild-type littermates. Zero was set as the baseline control, and data are plotted in a log10 scale. Graphs in the middle and right panels show the extravascular parasite density in g-WAT and pancreas on day 6 post-infection. For all experiments, measurements correspond to triplicate experiments obtained from 9–12 mice. Heatmaps correspond to the score of at least 100 measurements from at least 12 individual mice. Significance relative to untreated controls is shown as ∗∗∗ p < 0.001, ∗∗ p < 0.01, or ∗ p < 0.05. Error bars show SD. All relevant data used to generate this figure are included in (tabs 17–20). See also and .

    Techniques Used: Blocking Assay, Infection, Control, Genetically Modified

    CD36 facilitates T. brucei binding to and transmigration through the vascular endothelium (A) Schematic representation of static binding assay of T. brucei on plastic surfaces coated with recombinant mouse CD36 (rCD36). (B) Proportion of parasites attached to plastic surface, coated with various concentrations of recombinant mouse CD36 (rCD36). 1× PBS and 1% BSA were used as binding controls. (C) Parasite subcellular regions that bind to plastic surface. Following washouts, the proportion of parasites bound to plastic surface using the full body or the anterior end (which includes the mid-body and the free flagellum) were quantified. (D) Schematic representation of static binding assay of T. brucei on WT HUVEC and HUVECs expressing GFP or CD36. (E) Proportion of parasites attached to HUVECs (WT, GFP-, or CD36-expressing cells). Parasite attachment was quantified at six different time points (0.5, 1, 2, 4, 6, and 8 h). A statistical model considering time was performed. (F) Parasite subcellular regions that bind to HUVECs. Quantification was as described in (C). (G) Schematic representation of transwell assay of T. brucei on WT HUVEC and HUVECs expressing GFP or CD36. T. brucei were seeded on the top chamber for 1 h. (H) Proportion of parasites that migrated from the top to bottom chambers of the transwell assay (Boyden chamber). EC barrier consisted of WT HUVEC cells and HUVEC cells expressing GFP or CD36. For all panels, ANOVA tests were performed to determine significance. Significance is shown as ∗∗∗ p < 0.001, ∗∗ p < 0.01, or ∗ p < 0.05. Experiments were performed in triplicate, and 100 fields of view were quantified. Error bars show SD. All relevant data used to generate this figure are included in (tabs 21–23).
    Figure Legend Snippet: CD36 facilitates T. brucei binding to and transmigration through the vascular endothelium (A) Schematic representation of static binding assay of T. brucei on plastic surfaces coated with recombinant mouse CD36 (rCD36). (B) Proportion of parasites attached to plastic surface, coated with various concentrations of recombinant mouse CD36 (rCD36). 1× PBS and 1% BSA were used as binding controls. (C) Parasite subcellular regions that bind to plastic surface. Following washouts, the proportion of parasites bound to plastic surface using the full body or the anterior end (which includes the mid-body and the free flagellum) were quantified. (D) Schematic representation of static binding assay of T. brucei on WT HUVEC and HUVECs expressing GFP or CD36. (E) Proportion of parasites attached to HUVECs (WT, GFP-, or CD36-expressing cells). Parasite attachment was quantified at six different time points (0.5, 1, 2, 4, 6, and 8 h). A statistical model considering time was performed. (F) Parasite subcellular regions that bind to HUVECs. Quantification was as described in (C). (G) Schematic representation of transwell assay of T. brucei on WT HUVEC and HUVECs expressing GFP or CD36. T. brucei were seeded on the top chamber for 1 h. (H) Proportion of parasites that migrated from the top to bottom chambers of the transwell assay (Boyden chamber). EC barrier consisted of WT HUVEC cells and HUVEC cells expressing GFP or CD36. For all panels, ANOVA tests were performed to determine significance. Significance is shown as ∗∗∗ p < 0.001, ∗∗ p < 0.01, or ∗ p < 0.05. Experiments were performed in triplicate, and 100 fields of view were quantified. Error bars show SD. All relevant data used to generate this figure are included in (tabs 21–23).

    Techniques Used: Binding Assay, Transmigration Assay, Recombinant, Expressing, Transwell Assay


    Figure Legend Snippet:

    Techniques Used: Purification, Blocking Assay, Control, Virus, Plasmid Preparation, Recombinant, Chemotaxis Assay, Cell Migration Assay, Software

    Related Articles

    Control:

    Article Title: Organotypic endothelial adhesion molecules are key for Trypanosoma brucei tropism and virulence
    Article Snippet: .. HUVECs were transduced 24h after seeding with 1% lentiviral plasmids containing GFP (control) (pLenti-C-mGFT-P2A-Puro, Cat # PS100093, Origene) or CD36-GFP (NM_007643, Cat # MR227663L4, Origene) sequences. ..



    Similar Products

    91
    Hycult Biotech anti mouse cd36 antibody
    Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
    Anti Mouse Cd36 Antibody, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/CD36%2C+Mouse%2C+mAb+CRF+D2712/pmc13398632-15-0-9
    Average 91 stars, based on 1 article reviews
    anti mouse cd36 antibody - by Bioz Stars, 2026-11
    91/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec anti cd36
    Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
    Anti Cd36, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-mouse%2C+REAfinity/pmc13104797-79-28-29
    Average 93 stars, based on 1 article reviews
    anti cd36 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    93
    Bio-Rad cd36
    Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
    Cd36, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/Rat+anti+Mouse+CD36/pm42849443-1194-49-51
    Average 93 stars, based on 1 article reviews
    cd36 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti mouse cd3 viobright b515
    Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
    Anti Mouse Cd3 Viobright B515, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-human/pm41888511-227-34-38
    Average 94 stars, based on 1 article reviews
    anti mouse cd3 viobright b515 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    93
    Miltenyi Biotec pe anti mouse cd36
    Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
    Pe Anti Mouse Cd36, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-mouse%2C+REAfinity/pmc13006431-70-0-6
    Average 93 stars, based on 1 article reviews
    pe anti mouse cd36 - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti mouse cd3
    Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 <t>anti‐CD36</t> antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.
    Anti Mouse Cd3, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/CD36+Antibody%2C+anti-human/10__1016_slash_j__jphs__2026__02__004-82-10-48
    Average 94 stars, based on 1 article reviews
    anti mouse cd3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Charles River Laboratories mouse cd36 fl fl
    Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of <t>CD36,</t> LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.
    Mouse Cd36 Fl Fl, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/cd36+loxp+loxp+mice/pmc12721204-58-0-4
    Average 86 stars, based on 1 article reviews
    mouse cd36 fl fl - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    R&D Systems anticd36
    Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of <t>CD36,</t> LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.
    Anticd36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mouse+cd36/Mouse+CD36%2FSR-B3+Antibody/pm41365858-228-96-97
    Average 94 stars, based on 1 article reviews
    anticd36 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 anti‐CD36 antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.

    Journal: FEBS Open Bio

    Article Title: Lipopolysaccharide uptake is augmented in lipopolysaccharide‐tolerant mouse macrophage‐like cells via increased CD14 expression

    doi: 10.1002/2211-5463.70261

    Figure Lengend Snippet: Enhanced lipopolysaccharide (LPS) uptake in LPS‐tolerant RAW264.7 cells is inhibited by treatment with anti‐CD14 antibody. LPS tolerance was induced in RAW264.7 cells by pretreatment with 10 ng mL −1 LPS for 12 h. (A and C) LPS‐tolerant cells were treated with LPS‐Alexa488 in the presence or absence of (A) 2.5 μg mL −1 anti‐CD14 antibody (clone 4C1) and (C) 10 μg mL −1 anti‐CD36 antibody. The cells were analyzed using confocal microscopy. LPS‐Alexa488 (green), nuclei stained with DAPI (blue), and merged images with DIC are shown. Scale bars (20 μm) are shown in the top panel; all panels are at the same magnification. (B) LPS‐tolerant or nontolerant cells were treated with LPS‐Alexa488 in the presence of the indicated concentrations of anti‐CD14 antibody (clone 4C1). The fluorescence intensities of the cells analyzed by flow cytometry are shown. For clarity of comparison, the results are separated into four panels for each concentration of anti‐CD14 antibody: 0.63, 1.3, 2.5, and 5.0 μg mL −1 from top to bottom. The same histograms are presented in all panels for direct comparison: nontolerant cells treated with or without LPS‐Alexa488 and LPS‐tolerant cells treated with LPS‐Alexa488. The underlined values in the histograms indicate Geo MFIs. DAPI, 4′,6‐diamidino‐2‐phenylindole; DIC, differential interference contrast.

    Article Snippet: Anti‐mouse CD36 antibody (clone CRF D‐2712) was purchased from Hycult Biotech (Uden, Netherlands).

    Techniques: Confocal Microscopy, Staining, Fluorescence, Flow Cytometry, Comparison, Concentration Assay

    Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.

    Journal: iScience

    Article Title: Angiogenesis-independent VEGF signaling enhances exercise capacity by increasing fat oxidation in mice fed sulfur amino acid-restricted diets

    doi: 10.1016/j.isci.2025.114148

    Figure Lengend Snippet: Transcriptomics across muscle depots reveal metabolic shift from glycolytic toward oxidative (A) Experimental set up and color scheme used throughout and . (B) Fold changes of transcripts associated with fatty acid (FA) catabolism and transport as identified in supplementary Extended Data A in muscle of male mice ( n = 6) given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Pathway enrichment analysis of genes showing significant diet-by-muscle interaction effects. (D) Fold changes (SAAR vs. Con) of TCA cycle genes in EDL and soleus. (E) Representative blots of electron transport chain complexes. (F) Quantification of relative protein abundance normalized to vinculin of SDHB for EDL and soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (G) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL ( bottom ) in EDL ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. (H) Representative blots of CD36, LPL, and PDK4 and vinculin ( top ) and quantification of relative protein abundance normalized to vinculin of CD36, PDK4, and LPL from blots ( bottom ) in soleus ( n = 6) of male mice given ad libitum access to SAAR versus Con diet on day seven. All panels represent data from mice that were not subjected to endurance running. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets; significance is determined by p < 0.05. See also and . Raw data files for E are available in the supplement as ZIP file.

    Article Snippet: Mouse: CD36 fl/fl , Charles River Laboratories , N/A.

    Techniques: Control, Quantitative Proteomics

    SAAR increases muscle lipid flux without altering lipid pool sizes (A) Experimental design and color scheme used in A–3E and A. (B) Circulatory carbon flux ( n = 10–13) of 13 C 18 -U-Linolate of jugular-vein-catheterized male mice given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Ex vivo β-oxidation measured by incorporation of 3 H-palmitic acid in 3 H-H 2 O in muscles of male mice fed a Con or SAAR diet for seven days ( n = 15). (D) Representative fluorescence images ( left ) of BODIPY 493:503 (green), WGA647 (red), and DAPI (blue) staining in EDL cross sections (scale bar, 50 μm) and quantification of Bodipy + Intensity within fibers ( right ) of male mice fed a Con or SAAR for seven days ( n = 6). (E) Lipidomics analysis from muscle of male mice fed a Con or SAAR diet for seven days ( n = 6), summarized as normalized ion counts of each main lipid class. (F) Experimental set up and color scheme used in G, 3H, and D–S3I. (G) Percent change in body weight ( n = 16) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet after seven days. (H) Distance ran during a one-time maximal endurance test (n = 9–15) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet on day seven. B–E represent data from mice that were not subjected to endurance running, G and H represent data from mice subjected to maximal endurance testing. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets, or two-way ANOVA with Sidak multiple comparisons test between diets and muscle or genotype; significance is determined by p < 0.05. See also and , , and .

    Journal: iScience

    Article Title: Angiogenesis-independent VEGF signaling enhances exercise capacity by increasing fat oxidation in mice fed sulfur amino acid-restricted diets

    doi: 10.1016/j.isci.2025.114148

    Figure Lengend Snippet: SAAR increases muscle lipid flux without altering lipid pool sizes (A) Experimental design and color scheme used in A–3E and A. (B) Circulatory carbon flux ( n = 10–13) of 13 C 18 -U-Linolate of jugular-vein-catheterized male mice given ad libitum access to sulfur amino acid-restricted (SAAR) versus control (Con) diet for seven days. (C) Ex vivo β-oxidation measured by incorporation of 3 H-palmitic acid in 3 H-H 2 O in muscles of male mice fed a Con or SAAR diet for seven days ( n = 15). (D) Representative fluorescence images ( left ) of BODIPY 493:503 (green), WGA647 (red), and DAPI (blue) staining in EDL cross sections (scale bar, 50 μm) and quantification of Bodipy + Intensity within fibers ( right ) of male mice fed a Con or SAAR for seven days ( n = 6). (E) Lipidomics analysis from muscle of male mice fed a Con or SAAR diet for seven days ( n = 6), summarized as normalized ion counts of each main lipid class. (F) Experimental set up and color scheme used in G, 3H, and D–S3I. (G) Percent change in body weight ( n = 16) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet after seven days. (H) Distance ran during a one-time maximal endurance test (n = 9–15) of male WT and EC CD36−/− mice given ad libitum access to SAAR versus Con diet on day seven. B–E represent data from mice that were not subjected to endurance running, G and H represent data from mice subjected to maximal endurance testing. All data are shown as mean, and error bars indicate SD unless otherwise noted; p values indicate the significance of the difference by Student t test between diets, or two-way ANOVA with Sidak multiple comparisons test between diets and muscle or genotype; significance is determined by p < 0.05. See also and , , and .

    Article Snippet: Mouse: CD36 fl/fl , Charles River Laboratories , N/A.

    Techniques: Control, Ex Vivo, Muscles, Fluorescence, Staining